AAV hybrid serotypes: Improved vectors for gene delivery

Current Gene Therapy

Volumn 5, Issue 3, 2005, Pages 299-310

  Choi, Vivian W ^a   McCarty, Douglas M ^b   Samulski, R Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CELL TYPE; CHIMERA; CRYSTAL STRUCTURE; DRUG TARGETING; GENE THERAPY; GENETIC ENGINEERING; NONHUMAN; PROTEIN MODIFICATION; RECEPTOR BINDING; REVIEW; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CHARACTERIZATION; VIRUS HYBRID; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS MUTANT;

ANIMALS; CAPSID PROTEINS; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; RECOMBINATION, GENETIC; SEROTYPING;

ADENO-ASSOCIATED VIRUS; MIRIDAE;

EID: 21244491577     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523054064968     Document Type: Review

References (106)

1. Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., Jacobson, S. G., Hauswirth, W. W. and Bennett, J. (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. 28: 92-5.
2. Agbandje, M., McKenna, R., Rossmann, M. G., Strassheim, M. L. and Parrish, C. R. (1993) Structure determination of feline panleukopenia virus empty particles. Proteins 16: 155-71.
3. Alexander, I. E., Russell, D. W., Spence, A. M. and Miller, A. D. (1996) Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7: 841-50.
4. Amiss, T. J., McCarty, D. M., Skulimowski, A. and Samulski, R. J. (2003) Identification and characterization of an adeno-associated virus integration site in CV-1 cells from the African green monkey. J. Virol. 77: 1904-15.
5. Asfour, B., Baba, H. A., Scheld, H. H., Hruban, R. H., Hammel, D. and Byrne, B. J. (2002) Uniform long-term gene expression using adeno-associated virus (AAV) by ex vivo recirculation in rat-cardiac isografts. Thorac. Cardiovasc. Surg. 50: 347-50.
6. Atchison, R. W., Casto, B. C. and Hammon, W. M. (1965) Adenovirus-Associated Defective Virus Particles. Science 149: 754-6.
7. Auricchio, A., Kobinger, G., Anand, V., Hildinger, M., O'Connor, E., Maguire, A. M., Wilson, J. M. and Bennett, J. (2001) Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum. Mol. Genet. 10: 3075-81.
8. Auricchio, A., O'Connor, E., Hildinger, M. and Wilson, J. M. (2001) A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. Mol. Ther. 4: 372-4.
9. Bantel-Schaal, U. and zur Hausen, H. (1984) Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134: 52-63.
10. Bartlett, J. S., Kleinschmidt, J., Boucher, R. C. and Samulski, R. J. (1999) Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat. Biotechnol. 17: 181-6.
11. Bartlett, J. S., Wilcher, R. and Samulski, R. J. (2000) Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74: 2777-85.
12. Berns, K. I. and Linden, R. M. (1995) The cryptic life style of adeno-associated virus. Bioessays 17: 237-45.
13. Bossis, I. and Chiorini, J. A. (2003) Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J. Virol. 77: 6799-810.
14. Bowles, D. E., Rabinowitz, J. E. and Samulski, R. J. (2003) Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production. J. Virol. 77: 423-32.
15. Chiorini, J. A., Afione, S. and Kotin, R. M. (1999) Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J. Virol. 73: 4293-8.
16. Chiorini, J. A., Kim, F., Yang, L. and Kotin, R. M. (1999) Cloning and characterization of adeno-associated virus type 5. J. Virol. 73: 1309-19.
17. Chiorini, J. A., Yang, L., Liu, Y., Safer, B. and Kotin, R. M. (1997) Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol. 71: 6823-33.
18. Chipman, P. R., Agbandje-McKenna, M., Kajigaya, S., Brown, K. E., Young, N. S., Baker, T. S. and Rossmann, M. G. (1996) Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc. Natl. Acad. Sci. USA 93: 7502-6.
19. Clarke, J. K., McFerran, J. B., McKillop, E. R. and Curran, W. L. (1979) Isolation of an adeno associated virus from sheep. Brief report. Arch. Virol. 60: 171-6.
20. Conway, J. E., Zolotukhin, S., Muzyczka, N., Hayward, G. S. and Byrne, B. J. (1997) Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71: 8780-9.
21. Cottard, V., Mulleman, D., Bouille, P., Mezzina, M., Boissier, M. C. and Bessis, N. (2000) Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther. 7: 1930-9.
22. Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A. and Chiorini, J. A. (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97: 3428-32.
23. Di Pasquale, G., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A. and Chiorini, J. A. (2003) Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9: 1306-12.
24. Douar, A. M., Poulard, K., Stockholm, D. and Danos, O. (2001) Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75: 1824-33.
25. Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E. and Engelhardt, J. F. (1999) Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73: 10371-6.
26. Duan, D., Yue, Y., Yan, Z., Yang, J. and Engelhardt, J. F. (2000) Endosomal processing limits gene transfer to polarized air-way epithelia by adeno-associated virus. J. Clin. Invest. 105: 1573-87.
27. Dubielzig, R., King, J. A., Weger, S., Kern, A. and Kleinschmidt, J. A. (1999) Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes. J. Virol. 73: 8989-98.
28. During, M. J., Samulski, R. J., Elsworth, J. D., Kaplitt, M. G., Leone, P., Xiao, X., Li, J., Freese, A., Taylor, J. R., Roth, R. H., Sladek, J. R., Jr., O'Malley, K. L. and Redmond, D. E., Jr. (1998) In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther. 5: 820-7.
29. Farkas, S. L., Zadori, Z., Benko, M., Essbauer, S., Harrach, B. and Tijssen, P. (2004) A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus. J. Gen. Virol. 85: 555-61.
30. Flotte, T. R. (2001) Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy. Curr. Opin. Mol. Ther. 3: 497-502.
31. Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X. and Wilson, J. M. (2004) Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78: 6381-8.
32. Gao, G. P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J. and Wilson, J. M. (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99: 11854-9.
33. Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deleage, G. and Hallek, M. (1999) Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med. 5: 1052-6.
34. Han, W., Wind-Rotolo, M., Kirkman, R. L. and Morrow, C. D. (2004) Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Virology 330: 221-32.
35. Hansen, J., Qing, K., Kwon, H. J., Mah, C. and Srivastava, A. (2000) Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol. 74: 992-6.
36. Hansen, J., Qing, K. and Srivastava, A. (2001) Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol. 75: 4080-90.
37. Hauck, B., Chen, L. and Xiao, W. (2003) Generation and characterization of chimeric recombinant AAV vectors. Mol. Ther. 7: 419-25.
38. Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., Podsakoff, G. M., Nichols, T. C., Kurtzman, G. J. and High, K. A. (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5: 56-63.
39. Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N. and Wilson, J. M. (2001) Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75: 6199-203.
40. Hoggan, M. D., Blacklow, N. R. and Rowe, W. P. (1966) Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. USA 55: 1467-74.
41. Jacobson, E. R., Kopit, W., Kennedy, F. A. and Funk, R. S. (1996) Coinfection of a bearded dragon, Pogona vitticeps, with adenovirus- and dependovirus-like viruses. Vet. Pathol. 33: 343-6.
42. Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J. and Chiorini, J. A. (2001) Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75: 6884-93.
43. Kaludov, N., Handelman, B. and Chiorini, J. A. (2002) Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum. Gene Ther. 13: 1235-43.
44. Kaludov, N., Padron, E., Govindasamy, L., McKenna, R., Chiorini, J. A. and Agbandje-McKenna, M. (2003) Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4. Virology 306: 1-6.
45. Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K. and Daida, H. (2005) Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J. Virol. 79: 609-14.
46. Kaufmann, B., Simpson, A. A. and Rossmann, M. G. (2004) The structure of human parvovirus B19. Proc. Natl. Acad. Sci. USA 101: 11628-33.
47. Lewis, P. F. and Emerman, M. (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68: 510-6.
48. Li, J., Wang, D., Qian, S., Chen, Z., Zhu, T. and Xiao, X. (2003) Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors. Gene Ther. 10: 1807-13.
49. Llamas-Saiz, A. L. (1997) Structure determination of minute virus of mice. Acta. Crystallogr. D. Biol. Crystallogr. 53: 93-102.
50. Loiler, S. A., Conlon, T. J., Song, S., Tang, Q., Warrington, K. H., Agarwal, A., Kapturczak, M., Li, C., Ricordi, C., Atkinson, M. A., Muzyczka, N. and Flotte, T. R. (2003) Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther. 10: 1551-8.
51. Maheshri, N. and Schaffer, D. V. (2003) Computational and experimental analysis of DNA shuffling. Proc. Natl. Acad. Sci. USA 100: 3071-6.
52. McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P. and Samulski, R. J. (2003) Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in. vivo. Gene Ther. 10: 2112-8.
53. McCarty, D. M., Monahan, P. E. and Samulski, R. J. (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8: 1248-54.
54. McCown, T. J., Xiao, X., Li, J., Breese, G. R. and Samulski, R. J. (1996) Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713: 99-107.
55. Monahan, P. E., Samulski, R. J., Tazelaar, J., Xiao, X., Nichols, T. C., Bellinger, D. A., Read, M. S. and Walsh, C. E. (1998) Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5: 40-9.
56. Mori, S., Wang, L., Takeuchi, T. and Kanda, T. (2004) Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology 330: 375-83.
57. Muller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A. and Trepel, M. (2003) Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat. Biotechnol. 21: 1040-6.
58. Muramatsu, S., Mizukami, H., Young, N. S. and Brown, K. E. (1996) Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 221: 208-17.
59. Muzyczka, N. (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158: 97-129.
60. Nicklin, S. A., Buening, H., Dishart, K. L., de Alwis, M., Girod, A., Hacker, U., Thrasher, A. J., Ali, R. R., Hallek, M. and Baker, A. H. (2001) Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol. Ther. 4: 174-81.
61. Olson, E. J., Haskell, S. R., Frank, R. K., Lehmkuhl, H. D., Hobbs, L. A., Warg, J. V., Landgraf, J. G. and Wunschmann, A. (2004) Isolation of an adenovirus and an adeno-associated virus from goat kids with enteritis. J. Vet. Diagn. Invest. 16: 461-4.
62. Opie, S. R., Warrington, K. H., Jr., Agbandje-McKenna, M., Zolotukhin, S. and Muzyczka, N. (2003) Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol. 77: 6995-7006.
63. Parks, W. P., Melnick, J. L., Rongey, R. and Mayor, H. D. (1967) Physical assay and growth cycle studies of a defective adeno-satellite virus. J. Virol. 1: 171-80.
64. Perabo, L., Buning, H., Kofler, D. M., Ried, M. U., Girod, A., Wenchner, C. M., Enssle, J. and Hallek, M. (2003) In. vitro selection of viral vectors with modified tropism: the adeno-associated virus display. Mol. Ther. 8: 151-7.
65. Pinkenburg, O., Platz, J., Beisswenger, C,, Vogelmeier, C. and Bals, R. (2004) Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus. J. Virol. Methods 120: 119-22.
66. Ponnazhagan, S., Mahendra, G., Kumar, S., Thompson, J. A. and Castillas, M., Jr. (2002) Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J. Virol. 76: 12900-7.
67. Ponnazhagan, S., Wang, X. S., Woody, M. J., Luo, F., Kang, L. Y., Nallari, M. L., Munshi, N. C., Zhou, S. Z. and Srivastava, A. (1996) Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection. J. Gen. Virol. 77 ( Pt 6): 1111-22.
68. Qing, K., Khuntirat, B., Mah, C., Kube, D. M., Wang, X. S., Ponnazhagan, S., Zhou, S., Dwarki, V. J., Yoder, M. C. and Srivastava, A. (1998) Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in. vitro and murine tissues in. vivo. J. Virol. 72: 1593-9.
69. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V. and Srivastava, A. (1999) Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5: 71-7.
70. Rabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E. and Samulski, R. J. (2004) Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups. J. Virol. 78: 4421-32.
71. Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X. and Samulski, R. J. (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76: 791-801.
72. Rabinowitz, J. E., Xiao, W. and Samulski, R. J. (1999) Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology 265: 274-85.
73. Rose, J. A., Maizel, J. V., Jr., Inman, J. K. and Shatkin, A. J. (1971) Structural proteins of adenovirus-associated viruses. J. Virol. 8: 766-70.
74. Rutledge, E. A., Halbert, C. L. and Russell, D. W. (1998) Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72: 309-19.
75. Samulski, R. J., Berns, K. I., Tan, M. and Muzyczka, N. (1982) Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA 79: 2077-81.
76. Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T. and Engelhardt, J. F. (2000) Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 74: 9184-96.
77. Schmidt, M., Katano, H., Bossis, I. and Chiorini, J. A. (2004) Cloning and characterization of a bovine adeno-associated virus. J. Virol. 78: 6509-16.
78. Shi, W., Arnold, G. S. and Bartlett, J. S. (2001) Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum. Gene Ther. 12: 1697-711.
79. Shi, W. and Bartlett, J. S. (2003) RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism. Mol. Ther. 7: 515-25.
80. Simpson, A. A., Chipman, P. R., Baker, T. S., Tijssen, P. and Rossmann, M. G. (1998) The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 A resolution. Structure 6: 1355-67.
81. Snyder, R. O., Miao, C., Meuse, L., Tubb, J., Donahue, B. A., Lin, H. F., Stafford, D. W., Patel, S., Thompson, A. R., Nichols, T., Read, M. S., Bellinger, D. A., Brinkhous, K. M. and Kay, M. A. (1999) Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat. Med. 5: 64-70.
82. Song, S., Embury, J., Laipis, P. J., Berris, K. I., Crawford, J. M. and Flotte, T. R. (2001) Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 8: 1299-306.
83. Song, S., Morgan, M., Ellis, T., Poirier, A., Chesnut, K., Wang, J., Brantly, M., Muzyczka, N., Byrne, B. J., Atkinson, M. and Flotte, T. R. (1998) Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95: 14384-8.
84. Stilwell, J. L. and Samulski, R. J. (2004) Role of viral vectors and virion shells in cellular gene expression. Mol. Ther. 9: 337-46.
85. Summerford, C., Bartlett, J. S. and Samulski, R. J. (1999) AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5: 78-82.
86. Summerford, C. and Samulski, R. J. (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72: 1438-45.
87. Summerford, C. and Samulski, R. J. (1999) Viral receptors and vector purification: new approaches for generating clinical-grade reagents. Nat. Med. 5: 587-8.
88. Tomar, R. S., Matta, H. and Chaudhary, P. M. (2003) Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 22: 5712-5.
89. Tsao, J., Chapman, M. S., Agbandje, M., Keller, W., Smith, K., Wu, H., Luo, M., Smith, T. J., Rossmann, M. G., Compans, R. W. and et. al. (1991) The three-dimensional structure of canine parvovirus and its functional implications. Science 251: 1456-64.
90. Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S. and Zabner, J. (2004) Structure of adeno-associated virus serotype 5. J. Virol. 78: 3361-71.
91. Walters, R. W., Yi, S. M., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A. and Zabner, J. (2001) Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276: 20610-6.
92. Warrington, K. H., Jr., Gorbatyuk, O. S., Harrison, J. K., Opie, S. R., Zolotukhin, S. and Muzyczka, N. (2004) Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J. Virol. 78: 6595-609.
93. Weitzman, M. D., Fisher, K. J. and Wilson, J. M. (1996) Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol. 70: 1845-54.
94. Wistuba, A., Weger, S., Kern, A. and Kleinschmidt, J. A. (1995) Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol. 69: 5311-9.
95. Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T. and Muzyczka, N. (2000) Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol. 74: 8635-47.
96. Xia, H., Mao, Q., Eliason, S. L., Harper, S. Q., Martins, I. H., Orr, H. T., Paulson, H. L., Yang, L., Kotin, R. M. and Davidson, B. L. (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med 10: 816-20.
97. Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G. and Wilson, J. M. (1999) Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73: 3994-4003.
98. Xiao, W., Warrington, K. H., Jr., Hearing, P., Hughes, J. and Muzyczka, N. (2002) Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J. Virol. 76: 11505-17.
99. Xiao, X., Li, J. and Samulski, R. J. (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70: 8098-108.
100. Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A. and Chapman, M. S. (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA 99: 10405-10.
101. Xie, Q., Hare, J., Turnigan, J. and Chapman, M. S. (2004) Large-scale production, purification and crystallization of wild-type adeno-associated virus-2. J. Virol. Methods 122: 17-27.
102. Yan, Z., Zak, R., Luxton, G. W., Ritchie, T. C., Bantel-Schaal, U. and Engelhardt, J. F. (2002) Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76: 2043-53.
103. Yang, Q., Mamounas, M., Yu, G., Kennedy, S., Leaker, B., Merson, J., Wong-Staal, F., Yu, M. and Barber, J. R. (1998) Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy. Hum. Gene Ther. 9: 1929-37.
104. Ye, X., Rivera, V. M., Zoltick, P., Cerasoli, F., Jr., Schnell, M. A., Gao, G., Hughes, J. V., Gilman, M. and Wilson, J. M. (1999) Regulated delivery of therapeutic proteins after in. vivo somatic cell gene transfer. Science 83: 88-91.
105. Zhang, H. G., Xie, J., Dmitriev, I., Kashentseva, E., Curiel, D. T., Hsu, H. C. and Mountz, J. D. (2002) Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production. J. Virol. 76: 12023-31.
106. Zhang, W., Singam, R., Hellermann, G., Kong, X., Juan, H. S., Lockey, R. F., Wu, S. J., Porter, K. and Mohapatra, S. S. (2004) Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet. Vaccines Ther. 2: 8.